Table 1 List of included guidelines addressing dietary interventions for primary CVD prevention
GUIDELINE | AUTHOR | COUNTRY | YEAR | RATING SYSTEM (RS) | LINK TO EVIDENCE |
|---|---|---|---|---|---|
U.S. Preventive Services Task Force: Screening for and management of obesity in adults | USPSTF | USA | 2012 | USPSTF | Body of evidence after a table of graded recommendations |
Canadian Diabetes Association 2013 Clinical practice guidelines for the prevention and management of diabetes in Canada | Canadian Diabetes Association | Canada | 2013 | GRADE | Major evidence cited in a specific paragraph before the recommendation box |
2013 AHA/ACC guidelines on lifestyle management to reduce cardiovascular risk | ACC/AHA) | USA | 2014 | ACC/AHA Classification of Recommendation/Level of Evidence (COR/LOE) construct | Table to link the general critical question (CQ) + specific evidence statement developed in the CQ |
2013 AHA/ACC/TOS guidelines for the management of overweight and obesity in adults | ACC / AHA / TOS | USA | 2014 | ACC/AHA (COR/LOE) | Table to link the general CQ + specific evidence statement developed in the CQ |
Team-based care and improvement of blood pressure control: recommendation of the Community Preventive Services Task Force | Community Preventive Services Task Force | USA | 2014 | No RS | References at the end of the article (no link) |
Clinical practice guidelines for the management of overweight and obesity in adults, adolescents, and children in Australia | NHMRC | Australia | 2014 | NHMRC | Body of evidence after a table of graded recommendations |
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. CG181 | NICE | UK | 2014 | GRADE | Body of evidence first then recommendations |
Behavior change: individual approaches (PH49) | NICE | UK | 2014 | No RS | Isolated body of evidence (specific chapter) |
Cardiovascular disease prevention (PH25) | NICE | UK | 2014 | No RS | Isolated body of evidence (specific chapter) |
Guidelines for the management of absolute cardiovascular disease risk | NVDPA | Australia | 2014 | NHMRC | Body of evidence after a table of graded recommendations |
Prevention and Control of Noncommunicable Diseases. Guidelines for primary health care in low-resource settings | WHO | World | 2015 | GRADE | Body of evidence after each recommendation |
Maintaining a healthy weight and preventing excess weight gain among adults and children | NICE | UK | 2015 | No RS | Isolated body of evidence (specific chapter) |
Recommendations for prevention of weight gain and use of behavioral and pharmacological interventions to manage overweight and obesity in adults in primary care | Canadian Task Force on Preventive Health Care | Canada | 2015 | GRADE | Major evidence cited in a specific paragraph before the recommendation box |
Sugars intake for adults and children | WHO | World | 2015 | GRADE | Body of evidence after each recommendation |
Hypertension evidence-based nutrition practice guideline | ADA | USA | 2016 | Academy’s nutrition care process RS | Selected body of evidence after each recommendation |
Guideline for the management of dyslipidemia for the prevention of cardiovascular disease in the adult | Canadian 2016 Lipids Panel Members | Canada | 2016 | GRADE | Body of evidence after each recommendation |
Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement from the American Heart Association | ACC/AHA | USA | 2016 | ACC/AHA (COR/LOE) | Main references throughout the text |
The 2015 Dutch food-based dietary guidelines | Committee Dutch Dietary Guidelines | Netherlands | 2016 | No RS | Main references throughout the text |
Risk estimation and the prevention of cardiovascular disease | SIGN | UK | 2017 | SIGN | Body of evidence first then recommendations |
AACE/ACE Guidelines for the management of dyslipidemia and prevention of cardiovascular disease | AACE/ACE | USA | 2017 | AACE/ACE | Isolated body of evidence (specific chapter) |
Hypertension in adults: diagnosis and management (NG 136) | NICE | UK | 2019 | No RS | Isolated body of evidence (specific chapter) |
ACC/AHA Guideline on the primary prevention of cardiovascular disease | ACC/AHA | USA | 2019 | ACC/AHA (COR/LOE) | Body of evidence after each recommendation |
Updated Cardiovascular prevention guideline of the Brazilian society of cardiology | Brazilian Society of Cardiology | Brazil | 2019 | Brazilian Society of Cardiology RS | Main references throughout the text |
Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline | ADA/ European Endocrine Society | USA/Europe | 2019 | GRADE | Body of evidence after a table of graded recommendations |
Innovation to Create a Healthy and Sustainable Food System: A Science Advisory from the American Heart Association | AHA | USA | 2019 | No RS | Main references throughout the text |
ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | ESC/EAS | Europe | 2020 | ESC RS | Main references throughout the text |
Atherosclerotic cardiovascular disease risk assessment & management | Qatari Ministry of Health | Qatar | 2020 | Qatari RS | Main references throughout the text |
VA/DoD clinical practice guideline for screening and management of overweight and obesity | VA/DoD | USA | 2020 | GRADE | Body of evidence after each recommendation |
VA/DoD clinical practice guidelines for the diagnosis and management of hypertension in the primary care setting | VA/DoD | USA | 2020 | GRADE | Body of evidence after each recommendation |
VA/DoD clinical practice guidelines for the management of dyslipidemia for cardiovascular risk reduction | VA/DoD | USA | 2020 | GRADE | Body of evidence after each recommendation |
Outil d'aide au repérage précoce et intervention brève: alcool, cannabis, tabac chez l'adulte | HAS | France | 2021 | No RS | Main references throughout the text |
2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association | USPSTF | USA | 2021 | USPSTF RS | Report of the systematic review dedicated to one recommendation |
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | ESC | Europe | 2021 | ESC RS | Main references throughout the text |
Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement | USPSTF | USA | 2022 | USPSTF | Body of evidence after a table of graded recommendations |
Obesity prevention (CG189) | NICE | UK | 2022 | No RS | Isolated body of evidence (specific chapter) |
Comprehensive Management of Cardiovascular Risk Factors for Adults with Type 2 Diabetes: A Scientific Statement From the American Heart Association | AHA | USA | 2022 | No RS | Main references throughout the text |
Standards of Care in Diabetes—2023 | ADA | USA | 2022 | ADA RS | Body of evidence after a table of graded recommendations |
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement | USPSTF | USA | 2022 | USPSTF RS | Report of the systematic review dedicated to one recommendation |
Preventing type 2 diabetes—population and community interventions (PH35) | NICE | UK | 2022 | No RS | Isolated body of evidence (specific chapter) |